Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mahamed, D. A.
Right arrow Articles by Teng, Y.-T. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mahamed, D. A.
Right arrow Articles by Teng, Y.-T. A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 54:1477-1486, 2005
© 2005 by the American Diabetes Association, Inc.

G(–) Anaerobes–Reactive CD4+ T-Cells Trigger RANKL-Mediated Enhanced Alveolar Bone Loss in Diabetic NOD Mice

Deeqa A. Mahamed1,2, Annette Marleau2, Mawadda Alnaeeli1, Bhagirath Singh2, Xiaoxia Zhang1, Joseph M. Penninger3, and Yen-Tung A. Teng1,2

1 Eastman Department of Dentistry and Center for Oral Biology, Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York
2 Department of Microbiology and Immunology, Faculty of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada
3 Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria

Diabetic patients experience a higher risk for severe periodontitis; however, the underlying mechanism remains unclear. We investigated the contribution of antibacterial T-cell–mediated immunity to enhanced alveolar bone loss during periodontal infection in nonobese diabetic (NOD) mice by oral inoculation with Actinobacillus actinomycetemcomitans, a G(–) anaerobe responsible for juvenile and severe periodontitis. The results show that 1) inoculation with A. actinomycetemcomitans in pre-diabetic NOD mice does not alter the onset, incidence, and severity of diabetes; 2) after A. actinomycetemcomitans inoculation, diabetic NOD mice (blood glucose >200 mg/dl and with severe insulitis) exhibit significantly higher alveolar bone loss compared with pre-diabetic and nondiabetic NOD mice; and 3) A. actinomycetemcomitans–reactive CD4+ T-cells in diabetic mice exhibit significantly higher proliferation and receptor activator of nuclear factor {kappa}B ligand (RANKL) expression. When diabetic mice are treated with the RANKL antagonist osteoprotegerin (OPG), there is a significant reversal of alveolar bone loss, as well as reduced RANKL expression in A. actinomycetemcomitans–reactive CD4+ T-cells. This study clearly describes the impact of autoimmunity to anaerobic infection in an experimental periodontitis model of type 1 diabetes. Thus, microorganism-reactive CD4+ T-cells and the RANKL-OPG axis provide the molecular basis of the advanced periodontal breakdown in diabetes and, therefore, OPG may hold therapeutic potential for treating bone loss in diabetic subjects at high risk.


Address correspondence and reprint requests to Dr. Andy Y.-T. Teng, Laboratory of Molecular Microbial Immunity, Eastman Department of Dentistry and Center for Oral Biology, Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY, 14620. E-mail: andy_teng{at}urmc.rochester.edu

Abbreviations: CLN, cervical lymph node; FACS, fluorescence-activated cell sorter; FITC, fluorescein isothiocyanate; IL, interleukin; OPG, osteoprotegerin; RANK, receptor activator of nuclear factor {kappa}B; RANKL, RANK ligand; s-RANKL, soluble RANKL; STZ, streptozocin; TNF, tumor necrosis factor


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
R. Gyurko, C. C. Siqueira, N. Caldon, L. Gao, A. Kantarci, and T. E. Van Dyke
Chronic Hyperglycemia Predisposes to Exaggerated Inflammatory Response and Leukocyte Dysfunction in Akita Mice
J. Immunol., November 15, 2006; 177(10): 7250 - 7256.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Alnaeeli, J. M. Penninger, and Y.-T. A. Teng
Immune Interactions with CD4+ T Cells Promote the Development of Functional Osteoclasts from Murine CD11c+ Dendritic Cells.
J. Immunol., September 1, 2006; 177(5): 3314 - 3326.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
X. Zhang and Y.-T. A. Teng
Interleukin-10 Inhibits Gram-Negative-Microbe-Specific Human Receptor Activator of NF-{kappa}B Ligand-Positive CD4+-Th1-Cell- Associated Alveolar Bone Loss In Vivo.
Infect. Immun., August 1, 2006; 74(8): 4927 - 4931.
[Abstract] [Full Text] [PDF]


Home page
J. Dent. Res.Home page
Y.-T.A. Teng
Protective and Destructive Immunity in the Periodontium: Part 2--T-cell-mediated Immunity in the Periodontium.
J. Dent. Res., March 1, 2006; 85(3): 209 - 219.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2005 by the American Diabetes Association.